MediciNova Eulerpool Uudised

MediciNova Eulerpool News

MediciNova aktsia uudised

MediciNova jälgivad paljud ajakirjanikud ja investorid üle kogu maailma. Kõige värskemad MediciNova uudised paneme siia kokku.

• 4. september ·

  Yahoo
  MediciNova Announces Acceptance of Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial for Presentation at the 2024 Annual NEALS (Northeast Amyotrophic Lateral Sclerosis Consortium) Meeting
• 30. august ·

  Yahoo
  MNOV: Phase 3 ALS Readout in 2025…
• 30. august ·

  Seeking Alpha
  MediciNova gains after patent win for long COVID therapy
• 30. august ·

  Yahoo
  MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-166 (ibudilast) for the Post-COVID Condition
• 27. august ·

  Yahoo
  MediciNova (NASDAQ:MNOV) Is In A Good Position To Deliver On Growth Plans
• 19. august ·

  InvestorPlace
  MNOV Stock Earnings: MediciNova Beats EPS for Q2 2024
• 20. juuni ·

  Yahoo
  MediciNova Chief Business Officer David H. Crean, Ph.D. Assumes Communications Role Overseeing Investor Engagement and Public Relations
• 5. juuni ·

  Yahoo
  MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Various Solid Cancer
• 5. juuni ·

  Thefly.com
  MediciNova announces notice of allowance from USPTO for MN-166
• 4. juuni ·

  Yahoo
  MNOV: Multiple Abstracts Presented at 92nd EAS Congress…